Articles about 'Bill and Melinda Gates Foundation'

A Petri dish with a culture of the Superbug Acinetobacter baumannii next to antibiotics

Monoclonal antibodies offer hope for tackling antimicrobial resistance

16 September 2024

Monoclonal antibodies – treatments developed by cloning a cell that makes an antibody – could help provide an answer to the growing problem of antimicrobial resistance, say scientists.

Gates Cambridge: Class of 2022

21 April 2022

Meet some of this year’s 79 new scholars from 30 countries – including Sanjiv Ranchod from South Africa who will be starting a PhD in Computer Science in October.

Man walking past Stay Alert/Save Lives artwork

Key mutations in Alpha variant enable SARS-CoV-2 to overcome evolutionary weak points

29 June 2021

One of the key mutations seen in the ‘Alpha variant’ of SARS-CoV-2 – the deletion of two amino acids, H69/V70 – enables the virus to overcome cracks in its armour as it evolves, say an international team of scientists.

Gates Cambridge class of 2021

14 April 2021

Gates Cambridge, Cambridge's leading international postgraduate scholarship programme, announces its Class of 2021: 74 new Gates Cambridge Scholars-Elect will take up their postgraduate studies in October.

Study highlights risk of new SARS-CoV-2 mutations emerging during chronic infection

05 February 2021

SARS-CoV-2 mutations similar to those in the B1.1.7 UK variant could arise in cases of chronic infection, where treatment over an extended period can provide the virus multiple opportunities to evolve, say scientists.

Technique to regenerate the optic nerve offers hope for future glaucoma treatment

05 November 2020

Scientists have used gene therapy to regenerate damaged nerve fibres in the eye, in a discovery that could aid the development of new treatments for glaucoma, one of the leading causes of blindness worldwide.

Articles about 'Bill and Melinda Gates Foundation'

Monoclonal antibodies offer hope for tackling antimicrobial resistance

Gates Cambridge: Class of 2022

Key mutations in Alpha variant enable SARS-CoV-2 to overcome evolutionary weak points

Gates Cambridge class of 2021

Study highlights risk of new SARS-CoV-2 mutations emerging during chronic infection

Technique to regenerate the optic nerve offers hope for future glaucoma treatment

Connect with us

Study at Cambridge

About the University

Research at Cambridge